Nadolol Tablet
FDA Label NDC 70771-1090

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Nadolol (NDC 70771-1090). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1089-1

Nadolol tablets, 20 mg

Rx only

100 tablets

Nadolol Tablets (9f9ceff1 Ef9b 4cb4 A8a7 6f44fdbad972 01)

Nadolol Tablets (9f9ceff1 Ef9b 4cb4 A8a7 6f44fdbad972 01)

NDC 70771-1090-1

Nadolol tablets, 40 mg

Rx only

100 tablets

Nadolol Tablets (9f9ceff1 Ef9b 4cb4 A8a7 6f44fdbad972 02)

Nadolol Tablets (9f9ceff1 Ef9b 4cb4 A8a7 6f44fdbad972 02)

NDC 70771-1091-1

Nadolol tablets, 80 mg

Rx only

100 tablets

Nadolol Tablets (9f9ceff1 Ef9b 4cb4 A8a7 6f44fdbad972 03)

Nadolol Tablets (9f9ceff1 Ef9b 4cb4 A8a7 6f44fdbad972 03)

* Please review the disclaimer below.